CN108095074B - 一种辅助治疗骨质疏松症的金枪鱼鱼骨保健食品及其制备方法 - Google Patents
一种辅助治疗骨质疏松症的金枪鱼鱼骨保健食品及其制备方法 Download PDFInfo
- Publication number
- CN108095074B CN108095074B CN201711326011.9A CN201711326011A CN108095074B CN 108095074 B CN108095074 B CN 108095074B CN 201711326011 A CN201711326011 A CN 201711326011A CN 108095074 B CN108095074 B CN 108095074B
- Authority
- CN
- China
- Prior art keywords
- tuna
- residues
- fishbone
- collagen peptide
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013402 health food Nutrition 0.000 title claims abstract description 59
- 238000002360 preparation method Methods 0.000 title claims abstract description 50
- 208000001132 Osteoporosis Diseases 0.000 title claims abstract description 48
- 238000009098 adjuvant therapy Methods 0.000 title claims abstract description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 160
- 102000008186 Collagen Human genes 0.000 claims abstract description 61
- 108010035532 Collagen Proteins 0.000 claims abstract description 61
- 229920001436 collagen Polymers 0.000 claims abstract description 61
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 59
- 230000000694 effects Effects 0.000 claims abstract description 47
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims abstract description 35
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims abstract description 35
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims abstract description 35
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000011575 calcium Substances 0.000 claims abstract description 33
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 33
- 239000012154 double-distilled water Substances 0.000 claims abstract description 21
- 239000002775 capsule Substances 0.000 claims abstract description 19
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 17
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 15
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 15
- 239000011710 vitamin D Substances 0.000 claims abstract description 15
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 15
- 229940046008 vitamin d Drugs 0.000 claims abstract description 15
- 238000011049 filling Methods 0.000 claims abstract description 11
- 238000001694 spray drying Methods 0.000 claims abstract description 6
- 210000000988 bone and bone Anatomy 0.000 claims description 94
- 239000007788 liquid Substances 0.000 claims description 46
- 241000251468 Actinopterygii Species 0.000 claims description 41
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- 239000000843 powder Substances 0.000 claims description 26
- 238000000108 ultra-filtration Methods 0.000 claims description 22
- 238000005406 washing Methods 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 18
- 238000004440 column chromatography Methods 0.000 claims description 17
- 108090000145 Bacillolysin Proteins 0.000 claims description 16
- 102000035092 Neutral proteases Human genes 0.000 claims description 16
- 108091005507 Neutral proteases Proteins 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 14
- 238000002791 soaking Methods 0.000 claims description 14
- 239000012153 distilled water Substances 0.000 claims description 13
- 239000011347 resin Substances 0.000 claims description 13
- 229920005989 resin Polymers 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 10
- 230000001737 promoting effect Effects 0.000 claims description 10
- 239000002374 bone meal Substances 0.000 claims description 9
- 229940036811 bone meal Drugs 0.000 claims description 9
- 238000000605 extraction Methods 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 8
- 238000001816 cooling Methods 0.000 claims description 8
- 238000010828 elution Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 229920005654 Sephadex Polymers 0.000 claims description 7
- 239000012507 Sephadex™ Substances 0.000 claims description 7
- 102000004142 Trypsin Human genes 0.000 claims description 7
- 108090000631 Trypsin Proteins 0.000 claims description 7
- 239000012588 trypsin Substances 0.000 claims description 7
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 230000011164 ossification Effects 0.000 claims description 5
- 230000035755 proliferation Effects 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- 238000010992 reflux Methods 0.000 claims description 5
- 238000002390 rotary evaporation Methods 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- 229910021642 ultra pure water Inorganic materials 0.000 claims description 5
- 239000012498 ultrapure water Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- 239000004471 Glycine Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 4
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 4
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 4
- 239000004472 Lysine Substances 0.000 claims description 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 4
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 4
- 229930182817 methionine Natural products 0.000 claims description 4
- 239000004474 valine Substances 0.000 claims description 4
- 230000004663 cell proliferation Effects 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 9
- 231100000331 toxic Toxicity 0.000 abstract description 9
- 230000002588 toxic effect Effects 0.000 abstract description 9
- 230000009286 beneficial effect Effects 0.000 abstract description 6
- 239000000243 solution Substances 0.000 description 81
- 235000001465 calcium Nutrition 0.000 description 29
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- 239000002253 acid Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 230000001965 increasing effect Effects 0.000 description 8
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 229910001424 calcium ion Inorganic materials 0.000 description 7
- 238000009835 boiling Methods 0.000 description 6
- 230000037180 bone health Effects 0.000 description 6
- 230000009245 menopause Effects 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 4
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 4
- 230000004097 bone metabolism Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 235000020696 epimedium extract Nutrition 0.000 description 4
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 4
- 239000001630 malic acid Substances 0.000 description 4
- 235000011090 malic acid Nutrition 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000008055 phosphate buffer solution Substances 0.000 description 4
- 239000002686 phosphate fertilizer Substances 0.000 description 4
- 229920001184 polypeptide Polymers 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000008399 tap water Substances 0.000 description 4
- 235000020679 tap water Nutrition 0.000 description 4
- LEAHFJQFYSDGGP-UHFFFAOYSA-K trisodium;dihydrogen phosphate;hydrogen phosphate Chemical compound [Na+].[Na+].[Na+].OP(O)([O-])=O.OP([O-])([O-])=O LEAHFJQFYSDGGP-UHFFFAOYSA-K 0.000 description 4
- 230000032683 aging Effects 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 229940078480 calcium levulinate Drugs 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 230000011132 hemopoiesis Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000002386 leaching Methods 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- GONAVIHGXFBTOZ-UHFFFAOYSA-N 3,5-difluorobenzoic acid Chemical compound OC(=O)C1=CC(F)=CC(F)=C1 GONAVIHGXFBTOZ-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000893536 Epimedium Species 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 102000004067 Osteocalcin Human genes 0.000 description 2
- 108090000573 Osteocalcin Proteins 0.000 description 2
- 206010039984 Senile osteoporosis Diseases 0.000 description 2
- 102000007591 Tartrate-Resistant Acid Phosphatase Human genes 0.000 description 2
- 108010032050 Tartrate-Resistant Acid Phosphatase Proteins 0.000 description 2
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003674 animal food additive Substances 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 210000002805 bone matrix Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 235000018905 epimedium Nutrition 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 229960000890 hydrocortisone Drugs 0.000 description 2
- 201000000916 idiopathic juvenile osteoporosis Diseases 0.000 description 2
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 102000009310 vitamin D receptors Human genes 0.000 description 2
- 108050000156 vitamin D receptors Proteins 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 208000008312 Tooth Loss Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 210000002758 humerus Anatomy 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 230000002188 osteogenic effect Effects 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/75—Coating with a layer, stuffing, laminating, binding or compressing of original fish pieces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/60—Fish, e.g. seahorses; Fish eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Marine Sciences & Fisheries (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711326011.9A CN108095074B (zh) | 2017-12-12 | 2017-12-12 | 一种辅助治疗骨质疏松症的金枪鱼鱼骨保健食品及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711326011.9A CN108095074B (zh) | 2017-12-12 | 2017-12-12 | 一种辅助治疗骨质疏松症的金枪鱼鱼骨保健食品及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108095074A CN108095074A (zh) | 2018-06-01 |
CN108095074B true CN108095074B (zh) | 2021-02-02 |
Family
ID=62215717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711326011.9A Active CN108095074B (zh) | 2017-12-12 | 2017-12-12 | 一种辅助治疗骨质疏松症的金枪鱼鱼骨保健食品及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108095074B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111718825A (zh) * | 2020-06-24 | 2020-09-29 | 贵州古得宁酒业有限公司 | 一种具有补肾益阳作用的鲟鱼骨肽酒、其制备方法及应用 |
CN113072616B (zh) * | 2021-03-29 | 2022-05-31 | 浙江大学舟山海洋研究中心 | 一种促进成骨前体细胞增殖的功能肽微胶囊及其制备方法 |
CN113293129B (zh) * | 2021-03-29 | 2022-06-17 | 浙江大学舟山海洋研究中心 | 一种促进成骨前体细胞增殖的功能肽混合粉及其应用 |
CN114751975A (zh) * | 2021-11-15 | 2022-07-15 | 浙江省海洋开发研究院 | 一种金枪鱼骨胶原肽的制备方法及其应用 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004081137A (ja) * | 2002-08-28 | 2004-03-18 | Koki Kk | 栄養補助食品 |
CN1660196A (zh) * | 2004-12-13 | 2005-08-31 | 武汉健民中药工程有限责任公司 | 一种淫羊霍、骨碎补制成的中药提取物及制剂制备方法 |
CN101416995A (zh) * | 2007-10-24 | 2009-04-29 | 南京宇道科技开发有限公司 | 一种淫羊藿提取物及制备方法、制剂和用途 |
CN102178934A (zh) * | 2011-04-20 | 2011-09-14 | 威海博力生物工程有限公司 | 一种用于增加骨密度、防治骨关节病及增强免疫力的制剂 |
CN103992384A (zh) * | 2014-05-22 | 2014-08-20 | 浙江海洋学院 | 一种大黄鱼鱼骨胶原肽及其制备方法和用途 |
CN104710525A (zh) * | 2015-03-18 | 2015-06-17 | 浙江海洋学院 | 一种金枪鱼鱼骨胶原蛋白源锌螯合胶原肽及其制备方法和用途 |
CN104774896A (zh) * | 2015-04-15 | 2015-07-15 | 浙江海洋学院 | 带鱼鱼骨铁螯合胶原肽制备方法 |
CN105326861A (zh) * | 2015-09-23 | 2016-02-17 | 长春世鹿鹿业集团有限公司 | 一种鹿骨胶原肽和活性钙复剂的提取方法 |
CN106047970A (zh) * | 2016-06-21 | 2016-10-26 | 山东东方海洋科技股份有限公司 | 狭鳕鱼骨中胶原多肽与活性钙的提取方法 |
CN106755241A (zh) * | 2016-12-28 | 2017-05-31 | 北京化工大学 | 一种促进骨细胞生长的金枪鱼骨胶原多肽及其制备方法 |
-
2017
- 2017-12-12 CN CN201711326011.9A patent/CN108095074B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004081137A (ja) * | 2002-08-28 | 2004-03-18 | Koki Kk | 栄養補助食品 |
CN1660196A (zh) * | 2004-12-13 | 2005-08-31 | 武汉健民中药工程有限责任公司 | 一种淫羊霍、骨碎补制成的中药提取物及制剂制备方法 |
CN101416995A (zh) * | 2007-10-24 | 2009-04-29 | 南京宇道科技开发有限公司 | 一种淫羊藿提取物及制备方法、制剂和用途 |
CN102178934A (zh) * | 2011-04-20 | 2011-09-14 | 威海博力生物工程有限公司 | 一种用于增加骨密度、防治骨关节病及增强免疫力的制剂 |
CN103992384A (zh) * | 2014-05-22 | 2014-08-20 | 浙江海洋学院 | 一种大黄鱼鱼骨胶原肽及其制备方法和用途 |
CN104710525A (zh) * | 2015-03-18 | 2015-06-17 | 浙江海洋学院 | 一种金枪鱼鱼骨胶原蛋白源锌螯合胶原肽及其制备方法和用途 |
CN104774896A (zh) * | 2015-04-15 | 2015-07-15 | 浙江海洋学院 | 带鱼鱼骨铁螯合胶原肽制备方法 |
CN105326861A (zh) * | 2015-09-23 | 2016-02-17 | 长春世鹿鹿业集团有限公司 | 一种鹿骨胶原肽和活性钙复剂的提取方法 |
CN106047970A (zh) * | 2016-06-21 | 2016-10-26 | 山东东方海洋科技股份有限公司 | 狭鳕鱼骨中胶原多肽与活性钙的提取方法 |
CN106755241A (zh) * | 2016-12-28 | 2017-05-31 | 北京化工大学 | 一种促进骨细胞生长的金枪鱼骨胶原多肽及其制备方法 |
Non-Patent Citations (1)
Title |
---|
金枪鱼鱼骨活性钙对鼠胚胎成骨细胞前提细胞(MC3T3-E1)活力和凋亡作用;耿灵鑫等;《食品工业科技》;20170920(第3期);第311-314,319页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108095074A (zh) | 2018-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108095074B (zh) | 一种辅助治疗骨质疏松症的金枪鱼鱼骨保健食品及其制备方法 | |
CN107998333B (zh) | 一种阿胶肽制品的制备方法 | |
WO2009130005A2 (en) | Preparation and use of a plant extract from solanum glaucophyllum with an enriched content of 1,25-dihydroxyvitamin d3 glycosides and quercetin glycosides | |
CN101721458B (zh) | 一种人胎盘组织液的制备方法 | |
CN109793885B (zh) | 一种用于预防或缓解贫血的复合多肽的制备方法 | |
CN112890064A (zh) | 一种复合胶原蛋白肽固体饮料及其制备方法 | |
CN112438356A (zh) | 一种多元复合肽固体饮料及其制备方法 | |
Qin et al. | Physicochemical properties, digestibility and anti-osteoporosis effect of yak bone powder with different particle sizes | |
CN115399449A (zh) | 一种骨营养雪花片的制备方法 | |
CN107674905A (zh) | 螺旋藻活性肽、组合物及制备方法 | |
CN110720516A (zh) | 骨营养特膳食品及其制备方法和应用 | |
CN115969961B (zh) | 改善骨密度的钙、vd、蛋白肽组合物及其制备方法和应用 | |
RU2300898C2 (ru) | Способ экстрагирования, очистки и ферментативной модификации альфа`субъединицы 7s-глобулина сои для использования в качестве гипохолестеринемического агента | |
CN109180788B (zh) | 一种骆驼奶抗氧化多肽的制备方法及其应用 | |
CN113845565B (zh) | 一种地龙生物活性小肽及其制备方法和应用 | |
CN106820158A (zh) | 能引钙入骨且防止骨钙流失的补钙复剂及其制备方法 | |
CN109457009B (zh) | 一种小分子黄芪螯合肽的制备方法 | |
CN100363014C (zh) | 注射用骨瓜多肽药物组合物及其制备方法 | |
CN114098089A (zh) | 一种复合肽组合物及复合肽调味茶 | |
CN114315970A (zh) | 一种具有增肌作用的豌豆肽及其制备方法、药物和应用 | |
CN113519747A (zh) | 一种可调理肾脏的固体饮料及其制备方法 | |
CN112021577A (zh) | 一种具有卵巢保养功效的组合物 | |
CN113413395A (zh) | 一种含松脂醇二葡萄糖苷的组合物及其制备方法和应用 | |
CN113373194B (zh) | 一种能改善男性性功能的紫苏籽肽及其制备方法 | |
CN107114775B (zh) | 一种基于鮸鱼鱼鳔多肽的降血脂复配物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230302 Address after: No. 10, 6th Floor, Chengdu Digital Plaza, No. 1, Section 4, Renmin South Road, Wuhou District, Chengdu, Sichuan, 610041 Patentee after: Sichuan Qiye Century Enterprise Management Consulting Co.,Ltd. Address before: 316000 No. 1, Haida South Road, Changzhi Island, Lincheng street, Dinghai District, Zhoushan, Zhejiang. Patentee before: Zhejiang Ocean University |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230601 Address after: No. 1219, Building 1, No. 7 Shixing Street, Shijingshan District, Beijing, 100000 (cluster registration) Patentee after: Changsheng Wuji (Beijing) Biological Science Research Institute Co.,Ltd. Address before: No. 10, 6th Floor, Chengdu Digital Plaza, No. 1, Section 4, Renmin South Road, Wuhou District, Chengdu, Sichuan, 610041 Patentee before: Sichuan Qiye Century Enterprise Management Consulting Co.,Ltd. |
|
TR01 | Transfer of patent right |